Improving NHS staff conditions essential for service and patient outcomes

Looking after the NHS workforce is not only an ethical imperative but also a sound investment and must be a top priority, say experts in the third report of The BMJ Commission on the Future of the NHS.

Golden Hour Bundle of Interventions Boosts Outcomes for High-Risk Preterm Infants

WASHINGTON — A multidisciplinary quality improvement (QI) team successfully and safely adhered to a golden hour bundle of interventions for high-risk preterm infants, a researcher

October 23, 2023

Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted therapies for autoimmune disorders.

September 24, 2024

Japanese conglomerate to buy Calliditas Therapeutics, maker of a kidney disease drug

LONDON — Seeking to build up its pharma business, the Japanese conglomerate Asahi Kasei is moving to buy Swedish biotech Calliditas Therapeutics in a nearly

May 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.